Amgen
(NASDAQ) AMGN
Amgen Financials at a Glance
Market Cap
$183.26B
Revenue (TTM)
$36.77B
Net Income (TTM)
$7.71B
EPS (TTM)
$14.23
P/E Ratio
23.86
Dividend
$9.66
Beta (Volatility)
0.45 (Low)
Dividend
$9.66
Beta (Volatility)
0.45 (Low)
Price
$337.58
Volume
73,433
Open
$335.76
Price
$337.58
Volume
73,433
Open
$335.76
Previous Close
$339.57
Daily Range
$333.58 - $339.04
52-Week Range
$261.43 - $391.29
Dividend
$9.66
Beta (Volatility)
0.45 (Low)
Price
$337.58
Volume
73,433
Open
$335.76
Previous Close
$339.57
Daily Range
$333.58 - $339.04
52-Week Range
$261.43 - $391.29
AMGN News
Best Biotech ETFs to Buy in 2026
Dow Jones Industrial Average
AMGN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Amgen
Industry
Biotechnology
Sector
Health CareEmployees
31,500
CEO
Robert A. Bradway, MBA
Website
www.amgen.comHeadquarters
Thousand Oaks, CA 91320-1799, US
AMGN Financials
Key Financial Metrics (TTM)
Gross Margin
70%
Operating Margin
28%
Net Income Margin
21%
Return on Equity
106%
Return on Capital
16%
Return on Assets
9%
Earnings Yield
4.19%
Dividend Yield
2.84%
Payout Ratio
66.45%
Stock Overview
Market Cap
$183.26B
Shares Outstanding
539.69M
Volume
73.43K
Avg. Volume
2.72M
Financials (TTM)
Gross Profit
$26.01B
Operating Income
$10.68B
EBITDA
$15.84B
Operating Cash Flow
$9.96B
Capital Expenditure
$1.86B
Free Cash Flow
$8.10B
Cash & ST Invst.
$9.13B
Total Debt
$54.60B
Amgen Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$9.90B
+8.9%
Gross Profit
$8.11B
+35.7%
Gross Margin
81.91%
N/A
Market Cap
$183.26B
N/A
Market Cap/Employee
$6.55M
N/A
Employees
28,000
N/A
Net Income
$1.33B
+112.6%
EBITDA
$5.07B
+73.4%
Quarterly Fundamentals
Net Cash
$45.48B
+5.5%
Accounts Receivable
$9.57B
+27.6%
Inventory
$6.22B
-11.0%
Long Term Debt
$50.01B
-11.6%
Short Term Debt
$4.60B
+29.5%
Return on Assets
8.51%
N/A
Return on Invested Capital
15.81%
N/A
Free Cash Flow
$961.00M
-78.2%
Operating Cash Flow
$1.60B
-66.4%